News Notification

Harvard Diabetes and Obesity: Caring for the Whole Patient 2025

48 views Tags: CME Harvard Medical School

Updates, Guidance, and Best Practices for Patients with Diabetes

This unique conference is a response to the global burden of diseases driven by obesity and diabetes and acknowledges that clinicians and systems cannot manage one or the other when they are present in the same patient, but rather must address both together. Our unique curriculum is designed to activate members of the care team to manage both conditions holistically with an eye toward the health of both our patients and our communities. Included in this 3-day deep dive, we address evidence-based patient assessment, methods to support behavioral modification in different care settings, and in-depth discussion on use of current and emerging medications and procedures to guide clinicians to tailor therapeutic strategies to individuals struggling with metabolic disease. 

LEARNING OBJECTIVES

At the completion of this course, you should be able to:

  • Review and interpret up-to-date literature relevant to clinical practice.
  • Apply current/recommended guidelines in clinical practice.
  • Perform up-to-date techniques to diagnose complex clinical problems.
  • Identify/integrate current therapeutic options for obesity and diabetes.
  • Deliver equitable care with respect to race, ethnicity, gender, disability status, sexual preference, and gender orientation. 

HARVARD DIABETES AND OBESITY: CARING FOR THE WHOLE PATIENT 2025

0 0 votes
Article Rating

HARVARD DIABETES AND OBESITY: CARING FOR THE WHOLE PATIENT 2025 TOPICS

1. The Nature of Body Weight: What the Clinician Must Know – Lee Kaplan, MD

2. Cardiovascular Disease in Obesity and T2D – Jorge Plutzky, MD

3. The Spectrum of Kidney Disorders in Obesity & Diabetes – Sylvia Rosas, MD

4. Cancer and Metabolic Disease – Jeffrey A. Meyerhardt, MD

5. Ultra-Processed Foods: What are They and can They be Included as Part of a Healthy Diet? – Nancy Oliveira, MS, RD, LDN, CDCES

6. The Nutrition Prescription for People Living with Diabetes and Obesity – Janice MacLeod, MA, RD, CDCES, FADCES

7. Update on Vitamin D and Disease Prevention in Obesity – Anastasios Pittas, MD

8. When Should We Eat? The Importance of Meal Timing for Metabolic Control – Frank A. J. L. Scheer, MD

9. Why, When and How Should Obesity Medications be Prescribed? – Dong Wook Kim, MD

10. Exploration of Gut Hormone Drugs: Current Status and Pipeline – Vanita Aroda, MD

11. GLP-1 RA and GIP/GLP-1RAs for Metabolic Control & Risk Reduction – Lee-Shing Chang, MD

12. SGLT2is for Metabolic Control & Risk Reduction – Silvio Inzucchi, MD

13. Fatigue, Gastroparesis, Wrinkles, Oh My!: Practical Approach to Counseling Patients Before Starting GLP-1 RA and Related Drugs – Armen I. Yerevanian, MD

14. Incretin Therapies and the Pancreas: Evidence Review and Practical Points – Julia Mc Nabb-Baltar, MD, PhD

15. The Thyroid and Incretin Therapies: What We Do and Don’t Know – Erik Alexander, MD

16. Urination, Dehydration and Infection, Oh No!: Practical Approach to Counseling on SGLT2i Side Effect Profile – Kristen Fowler, MSN, FNP-BC, CDE

1. Obesity and Type 2 Diabetes – Caroline Apovian, MD

2. Effective Use of Cardiovascular Imaging to Evaluate CV Risk – Rhanderson Cardoso, MD

3. Evaluating Sleep, Obesity & Diabetes – Lawrence Epstein, MD

4. MASLD-Update on Screening and Treatment – Kathleen Viveiros, MD

5. Polycystic Ovary Syndrome in Obesity: Pearls and Pitfalls of Diagnosis and Management – Andrea Dunaif, MD

6. Get with the Guidelines: Addressing Healthcare Disparities – Nuha ElSayed, MD, MMSc

7. The Role of Racial Disparities in Outcomes: How to Address in the Clinic – Joshua Joseph, MD, MPH, FAHA

8. Depression in Obesity and Diabetes – Ashwini Nadkarni, MD

9. Weight Impact of Medications Commonly Prescribed in the Care of the Patient With Metabolic Disease – Louis Aronne, MD, FACP, DABOM

10. Recognizing Atypical Diabetes – Miriam Udler, MD, PhD

11. Lipodystrophy: How to Recognize in Your Practice – Lindsay Fourman, MD

12. “Double Diabetes”: Type 1 Diabetes with Overlap Features of Type 2 – Zeb Saeed, MD

13. Hypoglycemia – Devin Steenkamp, MD, MBChB

14. Wearable Devices to Achieve Clinical Targets: What Works? – John Jakicic, PhD

15. The Big Reveal: Use of Professional CGM in the Office to Identify Important Glycemic Patterns – Anna Goldman, MD

16. Self-Management with CGM: Selecting the Right Patient for Optimal Benefit – Grazia Aleppo, MD

17. The Ultimate Wearable: Exploring the Landscape of Automated Insulin Delivery – Melissa Putman, MD

1. The Continuum of Obesity and Type 2 Diabetes: Revisiting Treatment Goals – Vanita Aroda, MD

2. Putting it Together: Selecting Therapy for People with Diabetes – Marie McDonnell, MD

3. Adherence to Therapy in Chronic Disease – Niteesh Choudhry, MD, PhD

4. Remote Engagement: Medication Adherence – Julie Lauffenburger, MD, PhD, PharmD

5. Engagement of Patients and Providers in Online Weight Management Programs – Heather J. Baer, ScD

6. Activating Behavior Change in Your Patient: Motivational Interviewing Workshop – Joji Suzuki, MD

7. Effects of Metabolic Surgeries on Obesity and Diabetes – Ali Tavakkoli, MD

8. The Current State of Non-Surgical Metabolic Procedures: The Future is Now – Christopher Thompson, MD, MSc, FAGA, GACG, GASGE, FJGS

9. Patient Selection and the Peri-op Process for Metabolic Surgery – Scott Shikora, MD, FACS, FASMBS

10. Postoperative Nutritional Management – Malcolm Robinson, MD

11. Glycemic Challenges After Metabolic Surgery – Mary Elizabeth Patti, MD

12. Addressing Post-Bariatric Weight Re-gain – Nawfal Istfan, MD, PhD

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
error: Content is protected !!